These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 33191144)
1. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors. Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading. Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494 [TBL] [Abstract][Full Text] [Related]
3. Application of spectral CT combined with perfusion scan in diagnosis of pancreatic neuroendocrine tumors. Wan Y; Hao H; Chen Y; Zhang Y; Yue Q; Li Z Insights Imaging; 2022 Sep; 13(1):145. PubMed ID: 36057734 [TBL] [Abstract][Full Text] [Related]
4. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade. Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers. Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864 [TBL] [Abstract][Full Text] [Related]
6. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography. Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520 [TBL] [Abstract][Full Text] [Related]
8. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms. Li P; Zhu L; Xue H; Liu C; Xu K; Li J; Sun T; Jin Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):80-87. PubMed ID: 28270288 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography. Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. Canellas R; Burk KS; Parakh A; Sahani DV AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113 [TBL] [Abstract][Full Text] [Related]
13. CT texture analysis of liver metastases in PNETs versus NPNETs: Correlation with histopathological findings. Martini I; Polici M; Zerunian M; Panzuto F; Rinzivillo M; Landolfi F; Magi L; Caruso D; Eid M; Annibale B; Laghi A; Iannicelli E Eur J Radiol; 2020 Mar; 124():108812. PubMed ID: 31951893 [TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors. Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps. Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378 [TBL] [Abstract][Full Text] [Related]
17. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT. Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794 [TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421 [TBL] [Abstract][Full Text] [Related]
19. Low-dose whole organ CT perfusion of the pancreas: preliminary study. Li HO; Sun C; Xu ZD; Miao F; Zhang DJ; Chen JH; Li X; Wang XM; Liu C; Zhao B Abdom Imaging; 2014 Feb; 39(1):40-7. PubMed ID: 24258077 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]